Vanderbilt enhances its commitment to translational neuroscience research with a one-to-one match for new endowed gifts to the Warren Center.
Vanderbilt University recently announced the integration of the Warren Center for Neuroscience Drug Discovery into Discovery Vanderbilt—an initiative by the Office of the Provost that shares a name with one of the three pathways of the university’s Dare to Grow campaign.
“It’s so exciting to add the Warren Center for Neuroscience Drug Discovery into our Discovery Vanderbilt network of powerhouse research centers and institutes,” Provost and Vice Chancellor for Academic Affairs C. Cybele Raver said. “This underscores our steadfast commitment to pathbreaking advances in our understanding of brain and behavior, and it paves the way for translational solutions to neurodegenerative diseases that affect the lives of millions of Americans.”
The Warren Center aims to translate advances in basic science to novel therapeutics by “de-risking” innovative approaches for the treatment of serious brain disorders. De-risking involves contributing as much fundamental knowledge about a compound as possible during early stages of research to ensure that later development stages are fruitful.
To support this life-changing research, the university unveiled a corresponding one-to-one match for gifts to the Warren Center, an initiative within the Dare to Grow campaign. University matching, for qualifying gifts, will run from Dec. 1, 2023, through Dec. 31, 2024, or until the $2.5 million in match dollars are fulfilled.
To learn more, read the full story here.
